Bms America Inc. (Bristol Myers Squibb) is a leading global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for patients with serious diseases.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Bms America Inc. has recently focused on expanding its oncology and immunology portfolios through acquisitions, partnerships, and the launch of new therapies, reflecting broader industry trends toward precision medicine and biologics.
Acquisition of Mirati Therapeutics and Karuna Therapeutics to strengthen oncology and neuroscience pipelines
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Bms America Inc. (Bristol Myers Squibb) is a Fortune 500 biopharmaceutical company specializing in the development and commercialization of medicines that address serious diseases such as cancer, cardiovascular conditions, and autoimmune disorders. The company operates globally, with research and manufacturing facilities in North America, Europe, and Asia. BMS is known for its robust pipeline of innovative therapies and a legacy of scientific breakthroughs. Its portfolio includes leading products like Eliquis, Opdivo, and Revlimid, reflecting its focus on high-impact therapeutic areas.
